Glycosylation-driven bioactivity switching: Comparative pharmacology and translational prospects of oroxin and baicalein.

Summary: Oroxin and baicalein are natural plant compounds that show great promise for treating cancer, reducing inflammation, and protecting the heart. However, turning them into real medicines is tricky. Our bodies have a hard time absorbing them, and we do not know enough about their safety yet. The main difference between the two is a sugar molecule attached to oroxin. This sugar makes oroxin dissolve better in water, but it makes it harder to pass through cell walls. Scientists are now testing new ways to make and deliver these compounds, like using tiny "nano" packages, to help them work better and safely in the future.